Pharmacology Drug X which inhibit the binding of RANKL to its receptor (RANK) in osteoporosis: A Teriparatide B Alendronate C Denosumab D Estrogen π‘ Explanation Drug X which inhibit the binding of RANKL to its receptor (RANK) in osteoporosis: β Correct Answer: C. Denosumab